Send to

Choose Destination
Cathet Cardiovasc Diagn. 1988;15(2):76-80.

Value and limitations of intracoronary adenosine for the assessment of coronary flow reserve.

Author information

Catheterization Laboratory, Thoraxcenter, Erasmus University, Rotterdam, The Netherlands.


An ideal coronary vasodilator for studying coronary flow reserve should rapidly produce a maximal hyperemic response, be short acting to permit repeated measurements, and not alter systemic hemodynamics. We measured with a Doppler tip balloon catheter, in 12 patients before and/or after percutaneous transluminal coronary angioplasty the hyperemic response following 12.5 mg intracoronary papaverine and following gradually incremental bolus injections of intracoronary adenosine, starting from 0.05 mg until a maximal hyperemic response or side effects. The mean dose (+/- SD) of adenosine needed to produce maximal hyperemia was 0.23 (+/- 0.20 mg). Coronary blood flow velocity after adenosine increased to 1.6 +/- 0.3 times resting coronary blood flow velocity, comparable in magnitude to the hyperemia following intracoronary papaverine. The time from injection to peak effect after adenosine was 7.4 (SD +/- 2.2) sec and after papaverine 26 (SD +/- 7) sec. Adenosine resulted in a bradyarrhythmia in three patients. Intracoronary adenosine is a potent and very short acting vasodilator for studying coronary flow reserve, but the side effects and unpredictability of the dosage needed to produce maximal hyperemia may limit its applicability.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center